title: Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study.
abstract: Conflicting reports exist concerning the effect aspartame (APM, l-aspartyl-l-phenylalanine methyl ester) has upon brain biogenic amines. In the following study, in vivo voltammetry was utilized to measure evoked extracellular dopamine (DA) levels in the striatum of rats in order to assess APM's effect. Time-course experiments revealed a significant decline in evoked extracellular DA levels within 1h of a single systemic dose (500mg/kg i.p.) when compared to vehicle-injected controls. The effect was frequency dependent and showed a significant decrease utilizing high frequency stimulation parameters (50 and 60Hz). In order to further determine APM's potential to alter evoked extracellular DA levels, extended stimulation periods were employed to deplete releasable stores both before and after APM administration in intact and 6-OHDA partially lesioned animals. The extended stimulation periods were applied at 60Hz for 2,5,10 and 20s durations. APM decreased DA levels under these conditions in both intact and 6-OHDA partially lesioned animals by an average of 34% and 51%, respectively. Kinetic analysis performed on frequency series indicated that the diminished DA levels corresponded to a significant reduction in DA release. These findings suggest that APM has a relatively potent effect of decreasing evoked extracellular DA levels when administered systemically under the conditions specified.
authors.affiliation: Department of Biology, Neuroscience Program, Muskingum College, New Concord, OH 43762, USA. brianb@muskingum.edu
authors.forename: Brian P
authors.initials: BP
authors.lastname: Bergstrom
authors.forename: Deirdre R
authors.initials: DR
authors.lastname: Cummings
authors.forename: Tricia A
authors.initials: TA
authors.lastname: Skaggs
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001218:Aspartame / Q000494:pharmacology*; D001930:Brain Injuries / Q000139:chemically induced / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D003342:Corpus Striatum / Q000187:drug effects* / Q000473:pathology / Q000528:radiation effects; D004298:Dopamine / Q000378:metabolism*; D004307:Dose-Response Relationship, Radiation; D004558:Electric Stimulation / Q000379:methods; D004563:Electrochemistry / Q000379:methods; D045604:Extracellular Fluid / Q000187:drug effects* / Q000528:radiation effects; D008297:Male; D016627:Oxidopamine; D051381:Rats; D017207:Rats, Sprague-Dawley; D013549:Sweetening Agents / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D013549:Sweetening Agents; D016627:Oxidopamine; D004298:Dopamine; D001218:Aspartame